Perrigo (NYSE:PRGO) Stock Price Up 4.5% – Should You Buy?

Perrigo Company plc (NYSE:PRGO)’s share price traded up 4.5% during mid-day trading on Wednesday. The stock traded as high as $15.92 and last traded at $16.0660. Approximately 1,196,527 shares were traded during mid-day trading, a decline of 61% from the average session volume of 3,066,198 shares. The stock had previously closed at $15.37.

Analysts Set New Price Targets

Several research firms recently commented on PRGO. Wall Street Zen cut shares of Perrigo from a “strong-buy” rating to a “buy” rating in a research note on Sunday, September 27th. Weiss Ratings raised shares of Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a report on Thursday, August 6th. One research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $19.33.

Perrigo Stock Up 3.9%

The firm has a 50 day moving average of $14.20 and a 200-day moving average of $12.04. The company has a debt-to-equity ratio of 1.31, a current ratio of 2.32 and a quick ratio of 1.32. The stock has a market capitalization of $2.30 billion, a P/E ratio of -1.32, a price-to-earnings-growth ratio of 1.83 and a beta of 0.69.

Perrigo (NYSE:PRGO) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.50 EPS for the quarter, topping analysts’ consensus estimates of $0.39 by $0.11. Perrigo had a positive return on equity of 11.25% and a negative net margin of 41.85%. The company had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.02 billion. During the same quarter last year, the company earned ($0.06) EPS. The company’s quarterly revenue was down 3.1% on a year-over-year basis. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. On average, equities research analysts expect that Perrigo Company plc will post 2.18 earnings per share for the current fiscal year.

Perrigo Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Friday, August 28th were issued a $0.29 dividend. This represents a $1.16 annualized dividend and a yield of 7.0%. The ex-dividend date of this dividend was Friday, August 28th. Perrigo’s payout ratio is -9.27%.

Hedge Funds Weigh In On Perrigo

Hedge funds and other institutional investors have recently made changes to their positions in the business. Parrish Capital LLC boosted its position in shares of Perrigo by 4.3% during the 2nd quarter. Parrish Capital LLC now owns 33,896 shares of the company’s stock valued at $352,000 after acquiring an additional 1,384 shares in the last quarter. KBC Group NV raised its position in Perrigo by 61.3% in the first quarter. KBC Group NV now owns 6,283 shares of the company’s stock worth $67,000 after purchasing an additional 2,388 shares in the last quarter. Janney Montgomery Scott LLC lifted its stake in Perrigo by 9.6% during the first quarter. Janney Montgomery Scott LLC now owns 35,053 shares of the company’s stock worth $376,000 after purchasing an additional 3,073 shares during the period. GAMMA Investing LLC lifted its stake in Perrigo by 30.8% during the third quarter. GAMMA Investing LLC now owns 19,270 shares of the company’s stock worth $284,000 after purchasing an additional 4,537 shares during the period. Finally, Daytona Street Capital LLC lifted its stake in Perrigo by 16.7% during the third quarter. Daytona Street Capital LLC now owns 35,000 shares of the company’s stock worth $503,000 after purchasing an additional 5,000 shares during the period. 95.91% of the stock is owned by institutional investors.

About Perrigo

Perrigo Company plc (NYSE: PRGO) is a global consumer self-care company that develops, manufactures and sells over-the-counter (OTC) health and wellness products. Its portfolio includes products for pain relief, allergy and cold relief, digestive health, sleep support, skin care, women’s health and oral care. Perrigo supplies both its own brands and retailer-owned store brands.

The company markets products under a range of brand names, including Compeed, ACO, ellaOne and other regional brands, while also producing private-label alternatives to widely used consumer health products.